See also this year's filing and all EDGAR filings for this company.
PDF Report 0001467652_2017_Neos_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001467652')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001467652, Neos Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,269,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,076,000 |
| 3 | remainder_Assets | 17,797,000 |
| 4 | LiabilitiesCurrent | 21,645,000 |
| 5 | LiabilitiesNoncurrent | 60,045,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 11,437,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,625,000 |
| 9 | ResearchAndDevelopmentExpense | 12,207,000 |
| 10 | remainder_Expenses | 49,309,000 |
| 11 | remainder_Revenues | 9,154,000 |
| 12 | remainder_NetIncome | -6,909,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 80,142,000 |
| 1 | Liabilities | 81,690,000 |
| 2 | Expenses | 85,578,000 |
| 3 | Revenues | 9,154,000 |
| 4 | StockholdersEquity | -1,548,000 |
| 5 | NetIncome | -83,333,000 |
| 6 | ComprehensiveNetIncome | -83,333,500 |
| 7 | BaseVar | 131,737,000 |
| 8 | EconomicCapitalRatio | -1.06 |